Breaking News
1. AI breakthrough in breast cancer detection: New study claims over 17% improvement in screening accuracy      2. Inflows into equity mutual funds jump 14.5% to Rs 41,156 crore in December: AMFI      3. ONGC expects additional revenue of up to $10.3 billion from BP’s intervention in Mumbai High field      4. Pravasi Bharatiya Divas LIVE: India will fulfill world’s demand for skilled talent, says PM Modi      5. India-Taliban talks: Region in flux and 5 reasons behind Delhi’s decision to engage Kabul      6. California wildfire: Burning Los Angeles looks ‘apocalyptic’ in scary visuals      7. Tirupati stampede: Andhra Pradesh government announces ex-gratia of ₹25 lakh to next of kin of deceased      8. Massive fire at Varanasi railway station parking, over 200 vehicles gutted      9. First Sambhal, Then Ajmer: Ex-CJI Chandrachud Under Fire For ‘Opening Floodgates’ Of Survey Pleas      10. Chennai Airport Shut, Trains Hit As Cyclone Fengal Intensifies      11. 2nd Hindu Priest Arrested In Bangladesh Amid Protests: ISKCON Member      12. Man climbs mobile tower in Kota, threatens suicide over his tractor seizure      13. Body of 2-year-old, his grandmother recovered from river in Manipur      14. Bodies of six abducted in Jiribam found; Kerala CM and UDF leaders argue over BJP defection      15. Several flights, trains disrupted as Delhi covered in smog, visibility down      16. Delhi air quality: AQI at this Delhi station above 1500      17. Pawan Kalyan condemns deaths of 2 Hindu girls in Pakistan who faced ‘atrocities’      18. India not to travel to Pakistan for Champions Trophy, wants its matches in Dubai      19. India not to travel to Pakistan for Champions Trophy, wants its matches in Dubai      20. Samosas, cakes meant for Himachal Pradesh CM Sukhu served to his security staff instead; CID probe on     

Notice sent to Patanjali, but not under the key 1954 law

  • Posted on April 12, 2024
  • News
  • By Arijit Dutta
  • 389 Views

Official records and those with knowledge of the situation indicate that Patanjali Ayurveda was contacted by Uttarkhand's drug controller to provide answers about their misleading marketing that promised to treat severe illnesses miraculously.

Notice sent to Patanjali, but not under the key 1954 law Image Source -www.equitypandit.com

Instead of using the pertinent provisions of the Drugs & Magic Remedies Act, 1954, the advertisements were filed under a portion of the Drugs and Cosmetic Rules Act, 1945, which the Bombay High Court had halted.

It happened five times between April 2022 and February of current year. The company Patanjali, along with its managing director Balakrishna and public face Baba Ramdev, have come under fire from the Supreme Court for defying a court order to stop using these kinds of misleading marketing. The Indian Medical Association (IMA) filed a case, which prompted this move.

The duties of the states and the federal government have also been examined by the court.

Seemingly in response to these criticisms, the Union government last week published a public notice in several newspapers under the heading "Prohibition of advertisement of Ayurveda, Siddha, Unani& Homeopathy or any other drug or treatment of diseases mentioned in Schedule of Drugs & Magic Remedies Act, 1954." The Ministry of Health and Family Welfare issued the notification. The notification states that publications "claiming treatment of diseases" that are included in the previously specified schedule, as well as "publication of misleading advertisements making false claims," are prohibited by the Act.

Also Read:   Elon Musk's Starlink And Mukesh Ambani's Reliance Jio Compete For India's Internet Dominance

The reason behind the failure of Uttarakhand's drug controller, Ayurvedic and Unani Services, to inform Patanjali Ayurveda and its subsidiary, Divya Pharmacy, of this regulation is still unknown.

Drug controller sent notices to the corporation under Rule 170 of the Drugs and Cosmetic Rules Act, 1945, not the Drugs and Magic Remedies Act, 1954, according to information obtained by activist Dr. KV Babu of Kerala under the Right to Information (RTI) law. Rule 170 prohibits advertising Ayurvedic, Siddha, and Unani remedies without permission from the state licensing authority. The Bombay High Court postponed it in February 2019 in response to a petition made by the Ayurvedic Drug Manufacturers Association, of which Divya Pharmacy is a member.

 

Author
No Image
Author
Arijit Dutta

You May Also Like